Steven Cohen Sarepta Therapeutics, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $3.38 Million - $4.08 Million	33,000 New	33,000 $4 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.28 Million - $1.64 Million	16,500 New	16,500 $1.49 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $22.4 Million - $30.4 Million	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $10.7 Million - $15.2 Million	100,000 Added 100.0%	200,000 $23.8 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $5.4 Million - $8.23 Million	-100,000 Reduced 50.0%	100,000 $7.41 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $9.53 Million - $11.4 Million	200,000	200,000 $11.1 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.